X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2702) 2702
Book Review (457) 457
Publication (405) 405
Book Chapter (14) 14
Conference Proceeding (10) 10
Book / eBook (8) 8
Dissertation (5) 5
Newsletter (3) 3
Magazine Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2446) 2446
humans (1834) 1834
neisseria meningitidis (1102) 1102
microbiology (1019) 1019
neisseria meningitidis - genetics (937) 937
neisseria-meningitidis (865) 865
immunology (812) 812
infectious diseases (805) 805
meningitis (714) 714
vaccines (551) 551
meningococcal disease (517) 517
neisseria meningitidis - classification (510) 510
epidemiology (502) 502
meningococcal infections - microbiology (497) 497
female (494) 494
neisseria meningitidis - immunology (474) 474
animals (469) 469
male (444) 444
disease (432) 432
adolescent (430) 430
bacteria (423) 423
molecular sequence data (418) 418
neisseria meningitidis - isolation & purification (406) 406
adult (405) 405
research (403) 403
meningococcal infections - epidemiology (399) 399
child (393) 393
proteins (378) 378
serotyping (370) 370
child, preschool (351) 351
meningococcal vaccines - immunology (350) 350
infant (340) 340
bacterial proteins - genetics (336) 336
identification (326) 326
vaccination (306) 306
mice (299) 299
research article (298) 298
meningitis, meningococcal - microbiology (295) 295
meningococcal infections - prevention & control (290) 290
biochemistry & molecular biology (285) 285
meningitis, meningococcal - epidemiology (284) 284
antigens (280) 280
escherichia-coli (274) 274
neisseria meningitidis - pathogenicity (261) 261
vaccine (259) 259
serogroup (251) 251
base sequence (244) 244
immunization (243) 243
amino acid sequence (241) 241
genetic aspects (233) 233
medicine (231) 231
analysis (228) 228
health aspects (226) 226
outer-membrane protein (222) 222
multidisciplinary sciences (217) 217
serogroup-b (214) 214
antigens, bacterial - immunology (213) 213
disease outbreaks (213) 213
immunogenicity (211) 211
neisseria meningitidis - metabolism (210) 210
polymerase chain reaction (207) 207
medicine, research & experimental (202) 202
middle aged (202) 202
antigens, bacterial - genetics (201) 201
young adult (197) 197
epidemics (195) 195
bacterial proteins - metabolism (194) 194
gonorrhoeae (194) 194
mutation (194) 194
dna, bacterial - genetics (193) 193
virulence (190) 190
genotype (189) 189
meningococcal infections - immunology (186) 186
sequence analysis, dna (184) 184
children (181) 181
strains (181) 181
antibodies (179) 179
genetic variation (178) 178
meningitis, meningococcal - prevention & control (177) 177
meningococcal infections (176) 176
science (175) 175
genes (174) 174
neisseria meningitidis, serogroup b - immunology (174) 174
physiological aspects (173) 173
bacterial outer membrane proteins - genetics (172) 172
public health (172) 172
infections (171) 171
bacteriology (169) 169
neisseria meningitidis, serogroup b - genetics (167) 167
protein (167) 167
biology (163) 163
genomics (162) 162
meningococcal vaccines - administration & dosage (161) 161
genes, bacterial (159) 159
genomes (157) 157
carriage (156) 156
dna (148) 148
biotechnology & applied microbiology (144) 144
molecular epidemiology (144) 144
prevention (144) 144
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2684) 2684
French (19) 19
Russian (7) 7
Chinese (5) 5
Czech (5) 5
Spanish (5) 5
Portuguese (4) 4
Turkish (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Infection, ISSN 0163-4453, 2015, Volume 71, Issue 5, pp. 544 - 552
Summary Objectives Neisseria meningitidis is a leading cause of meningitis and septicaemia. The hyperinvasive ST-11 clonal complex (cc11) caused serogroup C... 
Infectious Disease | Meningococcal | Serogroup C | Genome | ST-11 clonal complex | Serogroup W | INFECTIOUS DISEASES | CLONAL COMPLEX | NEISSERIA-MENINGITIDIS | VACCINE | ET-15 CLONE | EMERGENCE | W135 | DISEASE | OUTBREAK | ET-37/ST-11 | STRAIN | Meningococcal Infections - epidemiology | Humans | Male | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Phylogeny | Multilocus Sequence Typing | Neisseria meningitidis, Serogroup B - isolation & purification | Endemic Diseases | South America - epidemiology | Homosexuality, Male | Disease Outbreaks | Neisseria meningitidis, Serogroup C - classification | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | France - epidemiology | Neisseria meningitidis, Serogroup C - genetics | South Africa - epidemiology | Serogroup | Neisseria meningitidis - isolation & purification | Neisseria meningitidis - classification | Neisseria meningitidis, Serogroup B - classification | North America - epidemiology | United Kingdom - epidemiology | Music in education | Epidemics | Respiratory tract diseases | Meningitis | Health aspects | Index Medicus | South America | Biochemistry, Molecular Biology | Genomics | United Kingdom | Neisseria meningitidis | North America | Life Sciences | Neisseria meningitidis, Serogroup C | South Africa | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup B | France | Meningococcal Infections
Journal Article
Journal of Immunology, ISSN 0022-1767, 07/2010, Volume 185, Issue 1, pp. 507 - 516
Properdin, a positive regulator of the alternative pathway (AP) of complement is important in innate immune defenses against invasive Neisserial infections.... 
C4B-BINDING PROTEIN | MOLECULAR-MECHANISM | SERUM RESISTANCE | FACTOR-H BINDING | COMPLEMENT DEFICIENCY STATES | SEROGROUP-B | HEREDITARY PROPERDIN | REGULATORY PROTEIN | FULMINANT MENINGOCOCCAL INFECTIONS | IMMUNOLOGY | CAPSULE NULL LOCUS | Neisseria meningitidis, Serogroup A - immunology | Neisseria meningitidis, Serogroup C - immunology | Humans | Neisseria meningitidis, Serogroup B - immunology | Neisseria meningitidis, Serogroup Y - genetics | Neisseria meningitidis, Serogroup B - genetics | Neisseria meningitidis, Serogroup B - metabolism | Neisseria meningitidis, Serogroup W-135 - metabolism | Neisseria meningitidis, Serogroup C - metabolism | Neisseria meningitidis, Serogroup A - metabolism | Neisseria meningitidis, Serogroup A - genetics | Neisseria gonorrhoeae - immunology | Complement Pathway, Alternative - genetics | Neisseria gonorrhoeae - genetics | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Bacterial Adhesion - immunology | Complement C3 - metabolism | Complement C3 Convertase, Alternative Pathway - metabolism | Properdin - physiology | Protein Binding - immunology | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup Y - metabolism | Neisseria meningitidis, Serogroup W-135 - immunology | Complement Pathway, Alternative - immunology | Enzyme Stability - immunology | Neisseria gonorrhoeae - metabolism | Properdin - isolation & purification | Properdin - metabolism | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2010, Volume 51, Issue 10, pp. 1127 - 1137
Background. In the absence of an efficacious broadly protective vaccine, serogroup B Neisseria meningitidis (MenB) is the leading cause of bacterial meningitis... 
Antigens | Immune response | Vaccination | Vaccine components | Antibodies | Experimentation | Neisseria meningitidis | ARTICLES AND COMMENTARIES | Dosage | Epidemiology | Blood | UNITED-STATES | INFECTIOUS DISEASES | NEW-ZEALAND | PROTECTION | NEISSERIA-MENINGITIDIS | COMPONENTS | ANTIBODY | MICROBIOLOGY | IMMUNOLOGY | MENINGITIDIS GROUP-B | IMMUNOGENICITY | BACTERICIDAL ACTIVITY | NADA | Adhesins, Bacterial - genetics | Humans | Antigens, Bacterial - immunology | Neisseria meningitidis, Serogroup B - immunology | Infant | Male | Neisseria meningitidis, Serogroup B - genetics | Vaccines, Synthetic - immunology | Meningococcal Vaccines - adverse effects | Meningitis, Meningococcal - immunology | Neisseria meningitidis, Serogroup B - chemistry | Vaccines, Synthetic - adverse effects | Drug-Related Side Effects and Adverse Reactions | Female | Immunization Schedule | Antibodies, Bacterial - blood | Bacterial Outer Membrane Proteins - genetics | Serum Bactericidal Antibody Assay | Bacterial Outer Membrane Proteins - immunology | United Kingdom | Meningitis, Meningococcal - prevention & control | Cell Membrane - immunology | Meningococcal Vaccines - immunology | Vaccines, Synthetic - administration & dosage | Adhesins, Bacterial - immunology | Meningococcal Vaccines - administration & dosage | Prevention | Infants (Newborn) | Bacterial meningitis | Research | Demographic aspects | Diseases | Disease prevention | Proteins | Membranes | Immunization | Infectious diseases | Clinical trials | Meningitis | Vaccines | Gram-negative bacteria | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 416 - 425
Summary Background A novel multicomponent vaccine against meningococcal capsular group B (MenB) disease contains four major components: factor-H-binding... 
Infectious Disease | ANTIBODIES | INFECTIOUS DISEASES | IMMUNOGENICITY | SEROGROUP-B VACCINE | PROTEIN | NADA | TOLERABILITY | NEISSERIA-MENINGITIDIS | SURVEILLANCE | DIVERSITY | RANDOMIZED CONTROLLED-TRIAL | Geography | Genes, Bacterial | Predictive Value of Tests | Meningococcal Vaccines - therapeutic use | Reproducibility of Results | Enzyme-Linked Immunosorbent Assay | Humans | Europe - epidemiology | Genotype | Neisseria meningitidis, Serogroup B - genetics | Adhesins, Bacterial - analysis | Antigens, Bacterial - genetics | Bacterial Typing Techniques - methods | Neisseria meningitidis, Serogroup B - isolation & purification | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - prevention & control | Multilocus Sequence Typing - methods | Meningitis, Meningococcal - microbiology | Neisseria meningitidis, Serogroup B - classification | DNA, Bacterial - analysis | Neisseria meningitidis, Serogroup B - pathogenicity | Population Surveillance - methods | Medical research | Glycosaminoglycans | Media coverage | Medicine, Experimental | Anticoagulants (Medicine) | Vaccines | Public health | Protein binding | Index Medicus | Europe | Antigens, Bacterial | Meningococcal Vaccines | Adhesins, Bacterial | Multilocus Sequence Typing | DNA, Bacterial | Meningitis, Meningococcal | Life Sciences | Human health and pathology | Infectious diseases | Bacterial Typing Techniques | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup B | Population Surveillance
Journal Article
Journal Article
Journal of Infection, ISSN 0163-4453, 2017, Volume 75, Issue 2, pp. 95 - 103
Journal Article
PLoS Pathogens, ISSN 1553-7366, 05/2011, Volume 7, Issue 5, pp. e1002027 - e1002027
During infection Neisseria meningitidis (Nm) encounters multiple environments within the host, which makes rapid adaptation a crucial factor for meningococcal... 
HUMAN EPITHELIAL-CELLS | FACTOR-H-BINDING | MICROBIOLOGY | SEROGROUP-B MENINGOCOCCUS | GENOME | PATHOGENIC NEISSERIAE | VACCINE CANDIDATES | VIROLOGY | OUTER-MEMBRANE PROTEIN | GENE-EXPRESSION | STAPHYLOCOCCUS-AUREUS | SERINE-PROTEASE | PARASITOLOGY | Adaptation, Physiological | Sequence Deletion | Virulence Factors - genetics | Genes, Bacterial - genetics | Humans | Neisseria meningitidis, Serogroup B - physiology | Transcriptome | Male | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Antigens, Bacterial - genetics | Bacteremia - microbiology | Bacteremia - blood | RNA, Bacterial - genetics | Adult | Female | Neisseria meningitidis, Serogroup B - pathogenicity | Bacterial Proteins - genetics | Up-Regulation - genetics | Down-Regulation - genetics | Neisseria meningitidis, Serogroup B - growth & development | Genome, Bacterial - genetics | Gene Expression Regulation, Bacterial - genetics | Host-Pathogen Interactions - genetics | Models, Biological | Meningococcal Infections - blood | Cluster Analysis | Causes of | Sepsis | Neisseria meningitidis | Genetic aspects | Research | Health aspects | Microbiology | Pathogenesis | Mortality | Genomes | Gene expression | Blood | Proteins | Studies | Evolutionary biology | Mutagenesis | DNA methylation | Meningitis | Deoxyribonucleic acid--DNA | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 8/2009, Volume 200, Issue 3, pp. 379 - 389
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2010, Volume 201, Issue 8, pp. 1208 - 1224
Background. A quadrivalent meningococcal conjugate vaccine (MCV4) was licensed in the United States in 2005; no serogroup vaccine is available. Neisseria... 
BACTERIA | Conjugate vaccines | Surveillance | Vaccination | Disease outbreaks | Medical genetics | Population structure | Neisseria meningitidis | Preventive medicine | Epidemiology | Genotypes | INFECTIOUS DISEASES | SEROGROUP-C | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | PNEUMONIAE SEROTYPE 19A | FETA | IDENTIFICATION | DISEASE | INFANTS | ZEALANDS EPIDEMIC | INFECTION | STRAIN | Meningococcal Vaccines - genetics | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Humans | Genotype | Meningococcal Infections - prevention & control | Neisseria meningitidis, Serogroup Y - genetics | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis - isolation & purification | Sequence Analysis, DNA | Bacterial Typing Techniques | Bacterial Capsules - genetics | Neisseria meningitidis - genetics | Meningococcal Vaccines - immunology | Antigenic Variation - genetics | Bacterial Outer Membrane Proteins - genetics | Usage | Physiological aspects | Genetic aspects | Research | Nucleotide sequencing | Membrane proteins | Index Medicus | Abridged Index Medicus | molecular epidemiology | multilocus sequence typing | fetA | population structure | capsular switching | outer membrane proteins | porA | porB | meningococcus, meningococcal | DNA sequencing
Journal Article
Journal of Infection, ISSN 0163-4453, 2017, Volume 74, Issue 6, pp. 564 - 574
Summary Objectives This work aimed to describe the epidemiology of invasive meningococcal disease (IMD) in France, 2006–2015, including group- and... 
Infectious Disease | Invasive meningococcal disease | Neisseria meningitidis | Meningococcal C conjugate vaccination | France | Epidemiology | INFECTIOUS DISEASES | CLONAL COMPLEX | CARRIAGE | NEISSERIA-MENINGITIDIS | VACCINATION | SEROGROUP | CHILDREN | PCR-BASED IDENTIFICATION | HERD-IMMUNITY | ASSOCIATION | VACCINES | Meningococcal Infections - epidemiology | Meningococcal Infections - mortality | Humans | Middle Aged | Child, Preschool | Cost of Illness | Infant | Male | Neisseria meningitidis, Serogroup B - genetics | Meningococcal Infections - microbiology | Neisseria meningitidis, Serogroup B - isolation & purification | Incidence | Young Adult | Adult | Female | Neisseria meningitidis - genetics | Neisseria meningitidis, Serogroup B - pathogenicity | Child | Neisseria meningitidis - pathogenicity | France - epidemiology | Genotype | Neisseria meningitidis - isolation & purification | Epidemics - statistics & numerical data | Vaccination - statistics & numerical data | Adolescent | Epidemics - prevention & control | Aged | Meningococcal Vaccines - administration & dosage | Meningitis | Vaccination | Genomics | Index Medicus | Meningococcal Vaccines/administration & dosage | Neisseria meningitidis/genetics | France/epidemiology | Neisseria meningitidis, Serogroup B/genetics | Meningococcal Infections/mortality | Neisseria meningitidis, Serogroup B/pathogenicity | Life Sciences | Neisseria meningitidis/pathogenicity | Neisseria meningitidis/isolation & purification | Epidemics/statistics & numerical data | Meningococcal Infections/microbiology | Biochemistry, Molecular Biology | Human health and pathology | Vaccination/statistics & numerical data | Epidemics/prevention & control | Infectious diseases | Meningococcal Infections/epidemiology | Neisseria meningitidis, Serogroup B/isolation & purification | Santé publique et épidémiologie
Journal Article
Vaccine, ISSN 0264-410X, 2010, Volume 28, Issue 37, pp. 6086 - 6093
Journal Article